IQVIA CFO Ron Bruehlman to Speak at Citi’s 2022 Virtual Healthcare Conference on February 24, 2022

Rhea-AI Summary

IQVIA Holdings Inc. (NYSE:IQV) announced that Ron Bruehlman, CFO, will participate in a virtual fireside chat at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022, at 11:00 a.m. ET. A live audio webcast will be available on the IQVIA Investor Relations website, with a replay accessible later that day. IQVIA is a global leader in analytics and clinical research services for life sciences, operating in over 100 countries with approximately 79,000 employees, focusing on improving healthcare outcomes through insights and technology.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 11:00 a.m. ET.

A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 79,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN

View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005864/en/

Nick Childs, IQVIA Investor Relations (nicholas.childs@iqvia.com)

+1.973.316.3828

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)

+1.484.567.6732

Source: IQVIA Holdings Inc.

FAQ

What will Ron Bruehlman discuss at the Citi Virtual Healthcare Conference?

Ron Bruehlman, CFO of IQVIA, will participate in a virtual fireside chat at the Citi 2022 Virtual Healthcare Conference.

When is IQVIA's appearance at the Citi Healthcare Conference?

IQVIA will participate in the Citi 2022 Virtual Healthcare Conference on Thursday, February 24, 2022, at 11:00 a.m. ET.

How can I access the IQVIA conference webcast?

The live audio webcast will be available on the IQVIA Investor Relations website, with a replay accessible later the same day.

What is IQVIA's main focus in the healthcare industry?

IQVIA focuses on advanced analytics, technology solutions, and clinical research services to improve healthcare outcomes.

How many employees does IQVIA have?

IQVIA has approximately 79,000 employees and operates in more than 100 countries.